NCT05228925View on ClinicalTrials.gov

GraviD-child Follow-up of the Children´s Health, Growth and Development Within the GraviD-study

CompletedOBSERVATIONAL
Enrollment

172

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

February 14, 2023

Conditions
Vitamin D DeficiencyBody CompositionVascular HealthCardiometabolic Risk
Interventions
OTHER

Maternal vitamin D status

Maternal vitamin D status (serum 25-hydroxyvitamin D) was collected during the GraviD study, while the woman was pregnant with the child now being followed-up in the GraviD-child study

Trial Locations (1)

41650

Queen Silvia Children's Hospital, Gothenburg

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Norwegian Institute of Public Health

OTHER_GOV

lead

Göteborg University

OTHER